ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Diamedica Therapeutics (DMAC)

Technical Analysis Report for USA stock DMAC Diamedica Therapeutics. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock DMAC Diamedica Therapeutics then click here. or read Experts views on Diamedica Therapeutics or Forecast & share price targets of Diamedica Therapeutics

Diamedica Therapeutics Opened at 9.36 and Closed at: 9.39, which is 0.53% of previous session's close. It moved within a range of 9.27 and 10.14
The session was a Bullish session with an average volume of 606000, which is 22.23% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 9.33 and resistance for tomorrow is 10.2
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 9.06, 8.73 resistance for tomorrow's hourly charts is 9.93, 10.47

10 Day SMA for Diamedica Therapeutics (DMAC) is 8.8 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Diamedica Therapeutics (DMAC) is 8.21 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Diamedica Therapeutics (DMAC) is 7.3 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 6.63 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Diamedica Therapeutics is 5.45 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Diamedica Therapeutics is at 8.21 and 200 DMA is at 5.45, while 50 DMA and 100 DMA are at 7.3 and 6.63 respectively

Diamedica Therapeutics (DMAC) moving average of 20 SMA is at 8.21 and 20 EMA is at 8.35

Diamedica Therapeutics (DMAC) moving average of 50 SMA is at 7.3 and 50 EMA is at 7.51

Diamedica Therapeutics (DMAC) moving average of 100 SMA is at 6.63 and 100 EMA is at 6.77

Diamedica Therapeutics (DMAC) moving average of 200 SMA is at 5.45 and 200 EMA is at 5.94

Diamedica Therapeutics has performed better than Davita Inc in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Regenxbio Inc in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Quidel Corporation in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Oramed Pharmaceuticals in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Organogenesis Holdings in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Karyopharm Therapeutics in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Kodiak Sciences in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Intuitive Surgical in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Immuron in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Integra Lifesciences in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Grifols S in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Fortress Biotech in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Dermira Inc in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Citius Pharmaceuticals in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Catalyst Biosciences in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics has performed better than Atossa Genetics in short term. Holding Diamedica Therapeutics could be a better choice for now!

Diamedica Therapeutics Technical analysis of indicators

Price action analysis of Diamedica Therapeutics (DMAC) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Diamedica Therapeutics in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Diamedica Therapeutics in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 8.91 and Diamedica Therapeutics DMAC stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Diamedica Therapeutics DMAC stock. Volume based technical analysis of Diamedica Therapeutics DMAC stock is negative.

Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock DMAC Diamedica Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And DMAC Experts View which covers a lot of information including buying and selling signals

DMAC future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Diamedica Therapeutics or View Candle Stick Charts here

Chart Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

Videos related to: Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

 

Back to top